"The subject of Bayer's problematic acquisition, used to illustrate the potential pitfalls of large-scale M&A."

"Strongly criticized for lobbying efforts to prevent lawsuits related to the health impacts of glyphosate, and for engaging in 'morally dubious' actions that compromise public health and competition."